Global Intravenous Iron Drugs Market By Product Type (Ferric carboxymaltose, Iron sucrose, Iron dextran, Iron derisomaltose, Sodium ferric gluconate, Others) By Application (Chronic kidney disease (CKD), Inflammatory bowel disease (IBD), Cancer- and chemotherapy-induced anemia, Obstetrics & gynaecology, Iron deficiency with heart failure, Others, By Patient Type (Adult, Pediatric, Geriatric) By End-User (Hospitals, Ambulatory care, Homecare settings, Specialty centers, Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Nov 2025
- Report ID: 168113
- Number of Pages: 322
- Format:
-
keyboard_arrow_up
-
-
- Vifor Pharma Management Ltd.
- Pharmacosmos A/S
- AMAG Pharmaceuticals, Inc.
- Sanofi S.A.
- Daiichi Sankyo Company, Ltd.
- AbbVie Inc. Company Profile
- Fresenius Kabi AG
- Baxter International Inc.
- Zydus Group
- Rockwell Medical, Inc.
- Viatris
- Emcure Pharmaceuticals Ltd.
- Nichi-Iko Pharmaceutical Co. Ltd.
- Lupin Ltd.
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible